Tax by asset class
The monthly sales exemption for shares
4 min
One of the most valuable — and most misunderstood — rules for individual investors in Brazilian stocks is the monthly sales exemption. Used well, it lets small investors realise gains tax-free. Misread, it lulls people into not paying tax they actually owe. The threshold below is the one at the time of writing; it has changed before and may change again — verify it.
The rule
If, in a calendar month, your total sales (vendas, the gross amount sold — not the profit) of common shares in swing trade stay at or below R$20,000, any profit on those sales is exempt from income tax.
Note the four conditions, all of which must hold:
- It is sales volume, not profit, that is measured against R$20,000.
- It applies to swing trade only — day trade has no exemption.
- It applies to ações (shares). It does not apply to ETFs or FIIs (different rules — see their lessons).
- Cross above R$20,000 in total sales that month and the entire profit becomes taxable, not just the excess.
A worked example
Month A: you sell R$18,000 of shares, profit R$4,000
→ sales ≤ R$20,000 → profit fully EXEMPT, no DARF
Month B: you sell R$25,000 of shares, profit R$4,000
→ sales > R$20,000 → entire R$4,000 taxed at 15% = R$600 DARF
The R$7,000 difference in sales between the months flips R$4,000 of profit from tax-free to a R$600 bill.
The practical strategy and the catch
Many small investors deliberately keep monthly sales under the threshold to harvest gains tax-free. Valid — but watch two traps: the limit is per month and resets, and selling exempt also means you cannot register a loss to offset future gains for those operations (you only track losses you actually declare). As always, educational only — confirm the current threshold and discuss your plan with an accountant.
This content is for educational and informational purposes only and is not investment, financial, tax or legal advice. Trading and investing carry risk, including the possible loss of capital. Any performance shown by third-party tools is hypothetical and not a promise of future results. Do your own research and consider professional advice before making any decision.